BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 20877266)

  • 1. Skin cancer after renal transplantation: Results of a multicenter study in Iran.
    Einollahi B; Nemati E; Lessan-Pezeshki M; Simforoosh N; Nourbala MH; Rostami Z; Nafar M; Pourfarziani V; Beiraghdar F; Mahdavi-Mazdeh M; Ahmadpour P; Makhdoomi K; Ghafari A; Ardalan MR; Taebi Khosroshahi H; Oliaei F; Shahidi S; Makhlogh A; Azmandian J; Samimagham HR; Shabazian H
    Ann Transplant; 2010; 15(3):44-50. PubMed ID: 20877266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoplastic skin lesions in Iranian renal transplant recipients: the role of immunosuppressive therapy.
    Zamanian A; Farshchian M
    J Drugs Dermatol; 2007 Jul; 6(7):703-6. PubMed ID: 17763593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort study.
    Braconnier P; Del Marmol V; Broeders N; Kianda M; Massart A; Lemy A; Ghisdal L; Le Moine A; Madhoun P; Racapé J; Abramowicz D; Wissing KM
    Nephrol Dial Transplant; 2012 Jun; 27(6):2547-53. PubMed ID: 22123748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: a review of single- and multicenter retrospective studies from 2006 to 2010.
    Mudigonda T; Levender MM; O'Neill JL; West CE; Pearce DJ; Feldman SR
    Dermatol Surg; 2013 Mar; 39(3 Pt 1):345-64. PubMed ID: 23190408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin tumors and skin infections in kidney transplant recipients vs. patients with pemphigus vulgaris.
    Sharquie KE; Noaimi AA; Al-Jobori AA
    Int J Dermatol; 2014 Mar; 53(3):288-93. PubMed ID: 23968536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi's sarcoma in renal transplant recipients: a report on 26 cases from a single institution.
    Qunibi WY; Barri Y; Alfurayh O; Almeshari K; Khan B; Taher S; Sheth K
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1402-5. PubMed ID: 8442155
    [No Abstract]   [Full Text] [Related]  

  • 8. Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression.
    Bernabeu-Wittel M; Naranjo M; Cisneros JM; Cañas E; Gentil MA; Algarra G; Pereira P; González-Roncero FJ; de Alarcón A; Pachón J
    Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):173-80. PubMed ID: 11957018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations.
    Zavos G; Karidis NP; Tsourouflis G; Bokos J; Diles K; Sotirchos G; Theodoropoulou E; Kostakis A
    Int J Dermatol; 2011 Dec; 50(12):1496-500. PubMed ID: 21790552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
    Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
    Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Risk Factors of Post-renal Transplantation Malignancies in North of Iran, A 20-year Experience.
    Nejatifar F; Monfared A; Khosravi M; Lebadi M; Shakiba M; Mokhtari G; Aghajanzadeh P; Haghdar-Saheli Y; Movasaghi A; Ramezanzadeh E; Akhondzadeh L
    Iran J Kidney Dis; 2020 Dec; 14(6):439-447. PubMed ID: 33277447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma in renal-transplant recipients: experience at the Catholic University in Rome, 1988-1996.
    Lesnoni La Parola I; Masini C; Nanni G; Diociaiuti A; Panocchia N; Cerimele D
    Dermatology; 1997; 194(3):229-33. PubMed ID: 9187838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancy after renal transplantation in the new era of immunosuppression.
    Watorek E; Boratynska M; Smolska D; Patrzalek D; Klinger M
    Ann Transplant; 2011; 16(2):14-8. PubMed ID: 21716180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety profile comparing azathioprine and mycophenolate in kidney transplant recipients receiving tacrolimus and corticosteroids.
    Cristelli MP; Tedesco-Silva H; Medina-Pestana JO; Franco MF
    Transpl Infect Dis; 2013 Aug; 15(4):369-78. PubMed ID: 23701592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post transplant Kaposi's sarcoma among Nigerians: a report of two cases.
    Abdu A; Adamu B; Sani MU; Mohammed AZ; Alhassan SU; Borodo MM
    Afr J Med Med Sci; 2005 Dec; 34(4):395-8. PubMed ID: 16752672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancers after renal transplantation: multicenter experience.
    Harzallah K; Abderrahim E; Chareffedine K; Yeich S; Belhadj R; Skhiri H; Younsi F; Abdallah TB; Abdelletif A; Hachicha J; Hmida J; El May M; Khedr A; Manaa J
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):825-30. PubMed ID: 18711309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttransplant lymphoproliferative disorders in kidney transplant recipients: an Iranian multicenter experience.
    Einollahi B; Lessan-Pezeshki M; Nourbala MH; Simforoosh N; Pourfarziani V; Nemati E; Nafar M; Basiri A; Pour-Reza-Gholi F; Firoozan A; Ghadiani MH; Makhdoomi K; Ghafari A; Ahmadpour P; Oliaei F; Ardalan MR; Makhlough A; Samimagham HR; Azmandian J; Razeghi E; Shahbazian H
    Iran J Kidney Dis; 2008 Oct; 2(4):227-33. PubMed ID: 19377242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does mycophenolate mofetil increase the incidence of infections in renal transplant recipients?
    Prokopenko E; Scherbakova E; Vatazin A; Pasov S; Budnikova N; Agafonova S
    Drugs Exp Clin Res; 2005; 31(5-6):199-205. PubMed ID: 16425976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.